The LEGATO project is proposing an investigator-initiated phase III randomised pragmatic clinical trial. We will assess whether the addition of radiation treatment to lomustine chemotherapy has superior efficacy as compared to lomustine chemotherapy alone for the treatment of patients with recurrent glioblastoma. The study will apply minimal patient eligibility criteria, and thus be as close as possible to the routine clinical setting.
Cost-effectiveness analysis will be performed to investigate the economic value of adding radiation treatment to lomustine chemotherapy in different countries to support evidence-informed policy decisions. If successful, the outcomes of the project will define a new evidence-based standard of care for recurrent glioblastoma.
We are a multidisciplinary and multistakeholder consortium involving clinical oncologists, radiation oncologists, health economists and patient representatives. The study design was successfully discussed with patients. This action is part of the Cancer Mission cluster of projects on ‘Diagnosis and treatment.”
© The LEGATO Consortium 2023-2028. This project has received funding from the European Union’s HORIZON-MISS-CANCER-2022-01 under grant agreement Nº (101103655). Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.
Company Details
- Founded
- -
- Address
- Brussels, Be
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- https://legato-horizon.eu/
- Keywords
- Legato Health Technologies.
- HQ
- Brussels
Legato Project Questions
Legato Project's website is https://legato-horizon.eu/
Legato Project's LinkedIn profile is https://be.linkedin.com/company/legato-horizon
Legato Project's industry is
Hospitals and Health Care
Legato Project's top competitors are
Strexit 2 Project,
Oncopost,
Nuclear Medicine And Neurooncology (Nmn),
Cioms,
Legato Health Technologies,
Immucan,
Cbig-Screen,
De-Escalate Project,
Eortc - European Organisation For Research And Treatment Of Cancer,
Co-Captain_eu.
Legato Project's categories are Hospitals and Health Care
Legato Project's founding year is 2023
